| Name | Title | Contact Details |
|---|
RepoSystems is a company that provides software tools to help manage the collateral recovery industry by utilizing the latest in technologies and business management processes.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Cloud-based productivity tool for professional investors to manage dealflow every day. #Dealflow #VentureCapital #VC #Saas #Productivity
Looking for home remodeling inspiration? Get ideas, cost guides and more on homeyou.com
Envisagenics is the latest bioinformatics spinout of Cold Spring Harbor Laboratory aiming to develop a predictive analytics platform for BioPharma